U.S. Cancer Biopsy Industry Overview The U.S. cancer biopsy market size was valued at USD 6.96 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.0% from 2021 to 2028.  The increasing popularity of image-guided needle biopsies in precision medicine applications and a rise in the adoption of biopsies based on multi-parametric Magnetic Resonance (MR)...